1620 Investment Advisors’s Amgen AMGN Stock Holding History

1620 Investment Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$78.9K	Hold	217	–	–	0.05%	278
2026 Q1	$76.6K	Sell	217 -60	-22%	-$21.4K	0.05%	268
2025 Q4	$90.9K	Sell	277 -1	-0.4%	-$317	0.06%	246
2025 Q3	$78.4K	Buy	278 +1	+0.4%	+$290	0.05%	258
2025 Q2	$77.6K	Sell	277 -1	-0.4%	-$283	0.06%	261
2025 Q1	$86.6K	Hold	278	–	–	0.07%	233
2024 Q4	$72.4K	Hold	278	–	–	0.05%	264
2024 Q3	$89.5K	Sell	278 -63	-18%	-$20.6K	0.06%	243
2024 Q2	$107K	Buy	+341	New	+$100K	0.08%	211

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

1620 Investment Advisors's AMGN Position: Q2 2026 in Review

1620 Investment Advisors held its Amgen (AMGN) position steady in Q2 2026 at 217 shares worth $78.9K. The position accounts for 0.05% of the portfolio, ranked #278.

1620 Investment Advisors first reported a position in AMGN in Q2 2024 and has held it in 9 quarters since. The position peaked at $107K in Q2 2024. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

1620 Investment Advisors held 217 shares of Amgen worth $78.9K as of Q2 2026.
1620 Investment Advisors left its Amgen share count unchanged in Q2 2026.
Amgen made up 0.05% of 1620 Investment Advisors's portfolio in Q2 2026, its #278 holding.
1620 Investment Advisors first reported a position in Amgen in Q2 2024 and has held it in 9 quarters since.
1620 Investment Advisors's Amgen position peaked at $107K in Q2 2024.
3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on 1620 Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.